India MCA Insolvency Liquidation Filings — March 10, 2026
The 9 filings in the India MCA Insolvency & Restructuring Monitor reveal a landscape dominated by prolonged Corporate Insolvency Resolution Processes (CIRPs) in infrastructure, textiles, and finance sectors, with 4 companies (Setubandhan, Morarjee Textiles, Reliance Home Finance, VAS Infrastructure) showing no resolution progress despite multi-year proceedings. Restructuring via amalgamations advances positively in healthcare (Aster DM meetings held, Indo National scheme sanctioned by NCLT Chennai on March 10, 2026), contrasting neutral voluntary liquidations of minor subsidiaries in IT/diagnostics (Tech Mahindra, Dr. Lal PathLabs) with negligible impact (e.g., Tech sub AUD 10.02 Mn revenue FY25, Dr Lal sub 7.37% turnover FY24). Limited financial data highlights distress: Setubandhan FY25 net loss ₹1.51 Cr on ₹23.22 L turnover amid persistent audit qualifications since FY23. No YoY/QoQ trends across portfolio due to sparse disclosures, but repetitive audit issues and rejected plans signal deteriorating net worth (Setubandhan ₹45.14 Cr). New filings (first 3) underscore Aster DM's scheme momentum and Setubandhan's stalled FY25 reporting. Overall, 5/9 neutral/negative sentiments indicate sector-wide distress, with catalysts like VAS NCLT hearing on March 20 offering turnaround potential. Market implication: Avoid prolonged CIRPs, monitor restructuring completions for alpha.